Evidence map›Paper›PMID 34635937›Full record

ArticleVirchows Archiv : an international journal of pathology2022

S100-negative epithelioid malignant peripheral nerve sheath tumor with possible perineurial differentiation.

Kyoko Yamashita, Yuki Funauchi, Keiko Hayakawa, Keisuke Ae, Seiichi Matsumoto, Kunihiro Ikuta, Yoshihiro Nishida, Teruko Ueno, Yoshie Shimoyama, Nobuyuki Hiruta and 3 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. The intriguing perineurial cells - an updated overview of their origin, structure, functions and implication in pathology.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Kyoko YamashitaDepartment of Pathology, the Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan. kyoko.yamashita@jfcr.or.jp.ORCID http://orcid.org/0000-0001-6535-5951
Yuki FunauchiDepartment of Orthopedic Oncology, the Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Keiko HayakawaDepartment of Orthopedic Oncology, the Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Keisuke AeDepartment of Orthopedic Oncology, the Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Seiichi MatsumotoDepartment of Orthopedic Oncology, the Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Kunihiro IkutaDepartment of Orthopedic Surgery, Nagoya University Graduate School and School of Medicine, Nagoya, Japan.
Yoshihiro NishidaDepartment of Orthopedic Surgery, Nagoya University Graduate School and School of Medicine, Nagoya, Japan.
Teruko UenoDiagnostic Imaging Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Yoshie ShimoyamaDepartment of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
Nobuyuki HirutaDivision of Pathology, the Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Rikuo MachinamiDivision of Pathology, the Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Hiroshi KawachiDepartment of Pathology, the Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.
Kengo TakeuchiDepartment of Pathology, the Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.
Japanese Foundation For Cancer Research · JPNagoya University Hospital · JPNagoya University · JPShowa General Hospital · JPThe Cancer Institute Hospital · JPToho University · JPTokyo Medical and Dental University · JP

Funding

japan society for the promotion of science 16K19079japan society for the promotion of science 19K16570
6 · The paper itself

Abstract

Epithelioid malignant peripheral nerve sheath tumor (MPNST) is a rare subtype of MPNST composed of epithelioid cells with abundant cytoplasm. Currently, strong and diffuse immunostaining for S100 protein and SOX10 is generally regarded as a characteristic feature of epithelioid MPNST. However, malignant tumors with epithelioid morphology that arise from a peripheral nerve or a pre-existing benign nerve sheath tumor should be regarded as epithelioid MPNSTs when they do not show characteristic features that definitively lead to other specific diagnoses. Here, we describe 3 cases of epithelioid MPNST in the peripheral nerve or schwannoma that was negative for S100 protein and SOX10 expression. Instead, these tumors were positive for EMA, GLUT1, claudin 1, and cytokeratin to varying degrees, while all of them retained SMARCB1 and H3K27me3 by immunohistochemistry. EMA, GLUT1, and claudin 1 are known markers of perineurial cell differentiation; thus, they could possibly represent epithelioid MPNST with perineurial cell differentiation.

Indexed as

NeurofibrosarcomaBiomarkers, TumorCell DifferentiationClaudin-1Glucose Transporter Type 1HumansPeripheral NervesS100 ProteinsSOXE Transcription FactorsBiomarkers, TumorClaudin-1Glucose Transporter Type 1S100 ProteinsSOX10 protein, humanSOXE Transcription FactorsEpithelioid malignant peripheral nerve sheath tumorEpithelioid MPNSTMalignant schwannomaPerineurial cell differentiation

Identifiers

PMID34635937
OpenAlexW3206630879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.